Symbols

VKTX

Viking Therapeutics·NASDAQ

--(--)

7.08 / 10

Outperform

Analysts are overwhelmingly positive: 50% Strong Buy, 50% Buy, with Morgan Stanley, Canaccord and JP Morgan showing 100% recent win rates. Fund‑flow score is 7.8/10 (good); small/medium inflows are positive, large/extra‑large are negative, supporting a bullish sentiment.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

50%

Buy

50%

Hold

Sell

Strong Sell

Date2025-11-12

InstitutionCanaccord Genuity

Times predicted2

Historical Win Rate50.0%

Is money flowing into or out of VKTX?

VKTX holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.08/10 (Outperform).